FOXC1 dosage is crucial since mutations that decrease FOXC1 activity below 80%, and FOXC1 duplications that increase FOXC1 copies to 150% both lead to ARS, with elevated IOP and glaucoma pathogenesis.[43]. This evidence concerns the gene FOXC1 and glaucoma.